Low albumin levels precede mucormycosis in pediatric cancer patients

Clicks: 4
ID: 337841
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #187 of 187 articles by views in medical mycology

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 187 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Mucormycosis remains a devastating fungal infection. Albumin has been proposed as a host defense mechanism against Mucorales with direct antifungal effects. In both matched and unmatched case-control analyses, serum albumin levels were lower in pediatric cancer patients with mucormycosis (N = 12) compared to children with other infections. Children with mucormycosis that died had significantly lower albumin levels than those who survived, whereas albumin levels were not associated with mortality in children with other infections. In addition, hypoalbuminemia preceded mucormycosis suggesting it may serve as a risk factor and potential therapeutic target.
Reference Key
openalex_W7224993019 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Yvette G.T. Loeffen, Wim Tissing, Roger J. M. Brüggemann, Frank L. van de Veerdonk, Jop Jans
Are you one of these authors? Claim your profile
Journal medical mycology
Year 2026
DOI
10.1093/mmy/myag117
URL
https://doi.org/10.1093/mmy/myag117
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.